Andrew Wang is a renowned physician scientist and radiation oncologist, whose passion lies in applying cutting-edge technology to create innovative procedures for cancer treatment and improve clinical practice. Wang holds a Bachelor's degree in Mathematics and Biology, Biochemistry from Indiana University Bloomington.

Wang has earned numerous accolades over the years, including the postdoctoral fellowship at MIT in Medical Physics, residency in radiation oncology from Harvard Radiation Oncology Program, and Doctor of Medicine (M.D.) from Harvard Medical School. Wang has also worked as an Associate Scientific Advisor at Science Translational Medicine and as an associate editor for various publications.

Wang's main area of focus is developing novel cancer therapies and translating them into clinical examples. He has co-founded several bioscience companies, including Acchiimmune Therapeutics and Capio Biosciences. In his role as a professor at the University of North Carolina at Chapel Hill, Wang shares his knowledge with the next generation of physicians and researchers by teaching biomedical engineering. Wang's interdisciplinary approach to research makes him a valuable contributor to the field of cancer care.